Tomáš has 13 years of experience in managing investment funds, venture capital and private transactions. He focussed on valuations, due diligence and tax structuring. Tomáš worked at PwC and spent more than 8 years in SME management, including mainly as CFO of several start-ups.
I believe HeartBeat.bio’s technology has real potential to contribute to more effective drug development to treat cardiovascular diseases. At the same time, I also see an ethical dimension, as the deployment of this technology will lead to a reduction in the number of animal experiments.
Site by
